Abstract
Recommendations for thromboprophylaxis in patients with LVADs are scarce. The International Society for Heart and Lung Transplantation has put together minimum criteria for perioperative anticoagulation; however, this is on the basis of poor level of evidence (observational studies and expert opinion). Ultimately, clinicians will need to individualize the intensity and timing of anticoagulation following LVAD implantation to ensure adequate thromboprophylaxis while simultaneously minimizing bleeding.
Original language | English (US) |
---|---|
Pages (from-to) | 192-196 |
Number of pages | 5 |
Journal | Current opinion in cardiology |
Volume | 30 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2015 |
Keywords
- Anticoagulation
- Bleeding
- Heart failure
- Left ventricular assist device
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine